nach oben

Forensische Psychiatrie, Psychologie, Kriminologie

Erschienen in:

28.03.2017 | ADHS | Übersicht

Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen – Risiko für Delinquenz im Jugend- und Erwachsenenalter?

verfasst von: Mirjam Just, Anna Kaiser, Wolfgang Retz, Michael Rösler, Tobias Banaschewski, Sarah Hohmann, Sabina Millenet

Erschienen in: Forensische Psychiatrie, Psychologie, Kriminologie | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) ist mit einer Prävalenz von etwa 5 % eine häufige, früh beginnende und persistierende Entwicklungsstörung. Die Ätiologie der ADHS ist komplex, heterogen, mit hohem genetischen Einfluss und vielfältigen neurobiologischen Alterationen. In mindestens 75 % der Fälle treten im Störungsverlauf weitere komorbide Störungen auf. Dieser Umstand erschwert die Diagnostik, verkompliziert die Therapie und verschlechtert die Prognose. Eine ADHS im Kindesalter erhöht das Risiko für delinquentes und auch antisoziales Verhalten im Jugend- oder frühen Erwachsenenalter, wobei die ADHS dabei als potenzieller Risikofaktor in einem komplexen, multifaktoriellen Zusammenspiel verstanden werden muss. Die Therapie der ADHS basierend auf Psychoedukation und der individuellen Kombination von Verhaltenstherapie sowie Psychopharmakotherapie beeinflusst den weiteren Verlauf der Kernsymptomatik und assoziierter psychiatrischer Störungen günstig, wobei insbesondere durch die medikamentöse Behandlung der ADHS eine bedeutsame Reduktion des Risikos für delinquentes Verhaltens erzielt werden kann.

Agnew-Blais JC, Polanczyk GV, Danese A, Wertz J, Moffitt TE, Arseneault L (2016) Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood. JAMA Psychiatry 73:713–720CrossRefPubMed

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5. Aufl. American Psychiatric Publishing, ArlingtonCrossRef

Angold A, Costello EJ, Erkanli A (1999) Comorbidity. J Child Psychol Psychiatry 40:57–87CrossRefPubMed

Banaschewski T, Brandeis D, Heinrich H, Albrecht B, Brunner E, Rothenberger A (2003) Association of ADHD and conduct disorder–brain electrical evidence for the existence of a distinct subtype. J Child Psychol Psychiatry 44:356–376CrossRefPubMed

Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Taylor E (2006) Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15:476–495CrossRefPubMed

Barkley RA, Fischer M, Smallish L, Fletcher K (2004) Young adult follow-up of hyperactive children: antisocial activities and drug use. J Child Psychol Psychiatry 45:195–211CrossRefPubMed

Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV (2009) Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics 124:71–78CrossRefPubMedPubMedCentral

Caspi A, Langley K, Milne B, Moffitt TE, O’Donovan M, Owen MJ, Taylor A (2008) A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 65:203–210CrossRefPubMed

Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Poulton R (2002) Role of genotype in the cycle of violence in maltreated children. Science 297:851–854CrossRefPubMed

Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, Rapoport JL (2002) Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 288:1740–1748CrossRefPubMed

Caye A, Rocha TB-M, Anselmi L, Murray J, Menezes AM, Barros FC, Steinhausen H‑C (2016) Attention-deficit/hyperactivity disorder trajectories from childhood to young adulthood: evidence from a birth cohort supporting a late-onset syndrome. JAMA Psychiatry 73(C):705–712CrossRefPubMed

Chang Z, Lichtenstein P, Halldner L, D’onofrio B, Serlachius E, Fazel S, Larsson H (2014) Stimulant ADHD medication and risk for substance abuse. J Child Psychol Psychiatry 55:878–885CrossRefPubMed

Coghill D (2010) The impact of medications on quality of life in attention-deficit hyperactivity disorder. CNS Drugs 24:843–866CrossRefPubMed

Dalsgaard S, Mortensen PB, Frydenberg M, Thomsen PH (2013) Long-term criminal outcome of children with attention deficit hyperactivity disorder. Crim Behav Ment Health 23:86–98. doi:10.1002/cbm.1860 CrossRefPubMed

Dalsgaard S, Ostergaard SD, Leckman JF, Mortensen PB, Pedersen MG (2015) Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet 385:2190–2196CrossRefPubMed

Daviss WB, Diler RS (2014) Suicidal behaviors in adolescents with ADHD: associations with depressive and other comorbidity, parent-child conflict, trauma exposure, and impairment. J Atten Disord 18:680–690CrossRefPubMed

De Sanctis VA (2010) The effects of childhood maltreatment on criminal and substance abuse outcomes in urban youth diagnosed with ADHD. City University of New York, New York

De Sanctis VA, Newcorn JH, Halperin, JM (2014) A prospective look at substance use and criminal behavior in urban ADHD youth: what is the role of maltreatment history on outcome? Atten Defic Hyperact Disord 6(2): 79–86

Deault LC (2010) A systematic review of parenting in relation to the development of comorbidities and functional impairments in children with attention-deficit/hyperactivity disorder (ADHD). Child Psychiatry Hum Dev 41:168–192CrossRefPubMed

DGKJP (2007) Leitlinie zu Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter. Deutscher Ärzte-Verlag, Köln

Elkins IJ (2011) Young children with ADHD are at increased risk of depression and suicidal behaviour in adolescence. Evid Based Ment Health 14:15CrossRefPubMed

Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, Franke B (2015) Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers 1:15020CrossRefPubMed

Faraone SV, Biederman J, Mick E (2006) The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 36:159–165CrossRefPubMed

Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313–1323CrossRefPubMed

Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, Jin R (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409CrossRefPubMed

Frodl T, Skokauskas N (2012) Meta‐analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatr Scand 125:114–126CrossRefPubMed

Goozen SH, Langley K, Northover C, Hubble K, Rubia K, Schepman K, Thapar A (2015) Identifying mechanisms that underlie links between COMT genotype and aggression in male adolescents with ADHD. J Child Psychol Psychiatry 57:472480

Gudjonsson GH, Sigurdsson JF, Sigfusdottir ID, Young S (2014) A national epidemiological study of offending and its relationship with ADHD symptoms and associated risk factors. J Atten Disord 18:3–13CrossRefPubMed

Hinshaw SP, Carte ET, Sami N, Treuting JJ, Zupan BA (2002) Preadolescent girls with attention-deficit/hyperactivity disorder: II. Neuropsychological performance in relation to subtypes and individual classification. J Consult Clin Psychol 70:1099CrossRefPubMed

Jensen CM, Steinhausen H‑C (2015) Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. ADHD Atten Deficit Hyperact Disord 7:27–38CrossRef

Langley K, Heron J, O’Donovan MC, Owen MJ, Thapar A (2010) Genotype link with extreme antisocial behavior: the contribution of cognitive pathways. Arch Gen Psychiatry 67:1317–1323CrossRefPubMed

Lichtenstein P, Halldner L, Zetterqvist J, Sjölander A, Serlachius E, Fazel S, Larsson H (2012) Medication for attention deficit–hyperactivity disorder and criminality. New Engl J Med 367:2006–2014CrossRefPubMedPubMedCentral

Ljung T, Chen Q, Lichtenstein P, Larsson H (2014) Common etiological factors of attention-deficit/hyperactivity disorder and suicidal behavior: a population-based study in Sweden. JAMA Psychiatry 71:958–964CrossRefPubMed

Lundstrom S, Forsman M, Larsson H, Kerekes N, Serlachius E, Langstrom N, Lichtenstein P (2014) Childhood neurodevelopmental disorders and violent criminality: a sibling control study. J Autism Dev Disord 44:2707–2716CrossRefPubMed

Man KK, Chan EW, Coghill D, Douglas I, Ip P, Leung L‑P, Wong IC (2015) Methylphenidate and the risk of trauma. Pediatrics 135:40–48CrossRefPubMed

Mannuzza S, Klein RG, Moulton JI (2008) Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records. Psychiatry Res 160:237–246CrossRefPubMedPubMedCentral

Moffitt TE, Scott S (2008) Conduct disorders. In: Rutter M, Bishop D, Pine D, Scott S, Stevenson J, Taylor E, Thapar A (Hrsg) Rutter’s child and adolescent psychiatry. Oxford, Blackwell

Mohr-Jensen C, Steinhausen HC (2016) A meta-analysis and systematic review of the risks associated with childhood attention-deficit hyperactivity disorder on long-term outcome of arrests, convictions, and incarcerations. Clin Psychol Rev 48:32–42CrossRefPubMed

Monuteaux MC, Biederman J, Doyle AE, Mick E, Faraone SV (2009) Genetic risk for conduct disorder symptom subtypes in an ADHD sample: specificity to aggressive symptoms. J Am Acad Child Adolesc Psychiatry 48:757–764CrossRefPubMed

Murray-Close D, Hoza B, Hinshaw SP, Arnold LE, Swanson J, Jensen PS, Wells K (2010) Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in The Multimodal Treatment Study of Children With ADHD: Developmental cascades and vicious cycles. Dev Psychopathol 22:785–802CrossRefPubMedPubMedCentral

Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch KP, Psychiatric GCAS (2010) Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49:884–897CrossRefPubMedPubMedCentral

NICE (2009) Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. National Institute for Health and Clinical Excellence, Leicester

Nigg JT (2005) Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade. Biol Psychiatry 57:1424–1435CrossRefPubMed

Nigg JT, Nikolas M (2008) Attention-deficit/hyperactivity disorder. In: Beauchaine TO, Hinshaw SP (Hrsg) Child and adolescent psychopathology. Wiley, Hoboken

Pfiffner LJ, McBurnett K, Rathouz PJ, Judice S (2005) Family correlates of oppositional and conduct disorders in children with attention deficit/hyperactivity disorder. J Abnorm Child Psychol 33:551–563CrossRefPubMed

Philipp-Wiegmann J, Rösler M, Clasen O, Zinnow T, Retz-Junginger P, Retz W (2017) ADHD modulates the course of delinquency: a 13 Year follow-upü study of young incarcerated man. Eur Arch Psychiat Clin Neurosci (Manuskript eingereicht)

Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942–948CrossRefPubMed

Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA (2014) ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol 43:434–442CrossRefPubMedPubMedCentral

Retz W, Retz-Junginger P, Hengesch G, Schneider M, Thome J, Pajonk FG, Rosler M (2004) Psychometric and psychopathological characterization of young male prison inmates with and without attention deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 254:201–208CrossRefPubMed

Retz W, Rösler M (2010) Association of ADHD with reactive and proactive violent behavior in a forensic population. Atten Defic Hyperact Disord 2:195–202CrossRefPubMed

Rösler M, Retz W, Retz-Junginger P, Hengesch G, Schneider M, Supprian T, Thome J (2004) Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci 254:365–371CrossRefPubMed

Rösler M, Retz W, Yaqoobi K, Burg E, Retz-Junginger P (2009) Attention deficit/hyperactivity disorder in female offenders: prevalence, psychiatric comorbidity and psychosocial implications. Eur Arch Psychiatry Clin Neurosci 259:98–105CrossRefPubMed

Satterfield JH, Swanson J, Schell AM, Lee F (1994) Prediction of antisocial behavior in attention-deficit hyperactivity disorder boys from aggression/defiant scores. J Am Acad Child Adolesc Psychiatry 33:185–190CrossRefPubMed

Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP, Greenstein D, Rapoport JL (2007) Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A 104:19649–19654CrossRefPubMedPubMedCentral

Shaw P, Malek M, Watson B, Sharp W, Evans A, Greenstein D (2012) Development of cortical surface area and gyrification in attention-deficit/hyperactivity disorder. Biol Psychiatry 72:191–197CrossRefPubMed

Shaw P, Stringaris A, Nigg J, Leibenluft E (2015) Emotion dysregulation in attention deficit hyperactivity disorder. Focus 14:127–144CrossRef

Solanto MV, Wasserstein J, Marks DJ, Mitchell KJ (2012) Diagnosis of ADHD in adults: what is the appropriate DSM-5 symptom threshold for hyperactivity-impulsivity? J Atten Disord 16:631–634CrossRefPubMed

Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Döpfner M (2013) Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 170:275–289CrossRefPubMed

Taylor E, Chadwick O, Heptinstall E, Danckaerts M (1996) Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Adolesc Psychiatry 35:1213–1226CrossRefPubMed

Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Sonuga-Barke E (2004) European clinical guidelines for hyperkinetic disorder–first upgrade. Eur Child Adolesc Psychiatry 13:7–30CrossRef

Thapar A, Cooper M (2016) Attention deficit hyperactivity disorder. Lancet 387:1240–1250CrossRefPubMed

WHO (1992) International classification of diseases and related health problems (10^th revision). WHO, Geneva

Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, Steinhausen HC (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21(C):655–679CrossRefPubMed

Young S, Moss D, Sedgwick O, Fridman M, Hodgkins P (2015) A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations. Psychol Med 45:247–258CrossRefPubMed

Young SJ, Adamou M, Bolea B, Gudjonsson G, Muller U, Pitts M, Asherson P (2011) The identification and management of ADHD offenders within the criminal justice system: a consensus statement from the UK Adult ADHD Network and criminal justice agencies. BMC Psychiatry 11:32CrossRefPubMedPubMedCentral

Ziegler E, Blocher D, Henkel K, Rösler M (2003) Symptome aus dem Spektrum des Hyperkinetischen Syndroms bei Häftlingen einer Justizvollzugsanstalt. Recht Psychiatr 21:17–21

Titel: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen – Risiko für Delinquenz im Jugend- und Erwachsenenalter?
verfasst von: Mirjam Just
Anna Kaiser
Wolfgang Retz
Michael Rösler
Tobias Banaschewski
Sarah Hohmann
Sabina Millenet
Publikationsdatum: 28.03.2017
Verlag: Springer Berlin Heidelberg
Schlagwörter: ADHS
ADHS
Störung des Sozialverhaltens
Substanzabusus
Substanzabusus
Erschienen in: Forensische Psychiatrie, Psychologie, Kriminologie / Ausgabe 2/2017
Print ISSN: 1862-7072
Elektronische ISSN: 1862-7080
DOI: https://doi.org/10.1007/s11757-017-0422-7

Neu im Fachgebiet Psychiatrie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen – Risiko für Delinquenz im Jugend- und Erwachsenenalter?

Zusammenfassung

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Schulabsentismus bei jugendlichen ALG-II-Empfängern aus Bedarfsgemeinschaften

Erratum zu: Möglichkeiten und Grenzen standardisierter Untersuchungsinstrumente

Kongresskalender

Psychiatrischer Beitrag

Folgen früher Traumatisierung aus neurobiologischer Sicht

Diagnostischer Nutzen einer strukturierten Erfassung von Verhaltensbeobachtungen des allgemeinen Vollzugdiensts im Jugendstrafvollzug

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie